Gerd Wegener

1.9k total citations
49 papers, 1.4k citations indexed

About

Gerd Wegener is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Gerd Wegener has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 25 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Gerd Wegener's work include Renal cell carcinoma treatment (22 papers), Renal and related cancers (12 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Gerd Wegener is often cited by papers focused on Renal cell carcinoma treatment (22 papers), Renal and related cancers (12 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Gerd Wegener collaborates with scholars based in Germany, Czechia and Nigeria. Gerd Wegener's co-authors include Henning Dralle, Oliver Gimm, H. Hundeshagen, Georg F. W. Scheumann, Andres Jan Schrader, Markus A. Kuczyk, A. Eckardt, Sandra Steffens, Mark Schrader and Christoph Seidel and has published in prestigious journals such as Journal of Hepatology, Annals of Oncology and European Urology.

In The Last Decade

Gerd Wegener

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerd Wegener Germany 20 749 477 457 385 298 49 1.4k
Haluk Onat Türkiye 11 753 1.0× 314 0.7× 147 0.3× 428 1.1× 121 0.4× 31 1.2k
Daniel Buitrago United States 16 325 0.4× 472 1.0× 285 0.6× 207 0.5× 156 0.5× 37 1.1k
Myles P. Cunningham United States 13 421 0.6× 237 0.5× 457 1.0× 387 1.0× 84 0.3× 22 1.1k
M. Colman United States 18 267 0.4× 348 0.7× 263 0.6× 255 0.7× 102 0.3× 40 1.1k
Yasser Khafaga Saudi Arabia 20 312 0.4× 300 0.6× 94 0.2× 454 1.2× 183 0.6× 49 1.3k
Yasemin Özlük Türkiye 18 270 0.4× 280 0.6× 154 0.3× 147 0.4× 178 0.6× 118 1.0k
L. Vini United Kingdom 18 507 0.7× 301 0.6× 909 2.0× 253 0.7× 75 0.3× 27 1.3k
Mitsuji Nagahama Japan 25 909 1.2× 164 0.3× 1.7k 3.7× 374 1.0× 241 0.8× 85 2.1k
W. King China 19 582 0.8× 147 0.3× 202 0.4× 186 0.5× 59 0.2× 29 1.2k
Kinji Nishiyama Japan 22 768 1.0× 727 1.5× 56 0.1× 521 1.4× 73 0.2× 63 1.6k

Countries citing papers authored by Gerd Wegener

Since Specialization
Citations

This map shows the geographic impact of Gerd Wegener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Wegener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Wegener more than expected).

Fields of papers citing papers by Gerd Wegener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Wegener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Wegener. The network helps show where Gerd Wegener may publish in the future.

Co-authorship network of co-authors of Gerd Wegener

This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Wegener. A scholar is included among the top collaborators of Gerd Wegener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Wegener. Gerd Wegener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roos, Frederik C., Sandra Steffens, Kerstin Junker, et al.. (2014). Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma. BMC Cancer. 14(1). 372–372. 26 indexed citations
2.
Eggers, Hendrik, Christoph Seidel, Andres Jan Schrader, et al.. (2013). Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladder. Medical Oncology. 30(4). 705–705. 37 indexed citations
3.
Steffens, Sandra, Julie Steinestel, Thomas Schnoeller, et al.. (2013). Elevated C-reactive protein values predict nodal metastasis in patients with penile cancer. BMC Urology. 13(1). 53–53. 23 indexed citations
4.
5.
Kramer, Mario W., A. Heinisch, Gerd Wegener, et al.. (2013). C-reaktives Protein vor radikaler Zystektomie. Der Urologe. 53(2). 222–227. 6 indexed citations
6.
Steffens, Sandra, Julie Steinestel, Gerd Wegener, et al.. (2013). High CRP values predict poor survival in patients with penile cancer. BMC Cancer. 13(1). 223–223. 31 indexed citations
7.
Schrader, Andres Jan, et al.. (2013). Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinoma. BMC Cancer. 13(1). 101–101. 27 indexed citations
8.
Steffens, Sandra, Martin Janssen, Frederik C. Roos, et al.. (2012). Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma – A multicentre study. European Journal of Cancer. 48(15). 2347–2352. 90 indexed citations
9.
Steffens, Sandra, Hendrik Eggers, Christoph Seidel, et al.. (2012). Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients. BMC Cancer. 12(1). 399–399. 71 indexed citations
10.
Ciesek, Sandra, et al.. (2011). 1020 EPIDEMIOLOGICAL TRENDS IN INCIDENCE AND MORTALITY OF HEPATOBILIARY CANCERS IN GERMANY. Journal of Hepatology. 54. S406–S406. 5 indexed citations
11.
Klot, Christoph von, Christoph Seidel, Gerd Wegener, et al.. (2011). The role of diabetes mellitus in localized and metastatic renal cell carcinoma. Journal of Diabetes Mellitus. 1(4). 104–108.
12.
Waalkes, Sandra, Frederik C. Roos, Hendrik Eggers, et al.. (2011). Inzidenz und Langzeitprognose des papillären Nierenzellkarzinoms. Der Urologe. 50(9). 1125–1129. 2 indexed citations
13.
Waalkes, Sandra, Thomas Herrmann, Gerd Wegener, et al.. (2011). Does Male Sex Influence the Prognosis of Patients with Renal Cancer?. Onkologie. 34(1-2). 24–28. 5 indexed citations
14.
Hahn, Thomas von, Sandra Ciesek, Gerd Wegener, et al.. (2011). Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scandinavian Journal of Gastroenterology. 46(9). 1092–1098. 83 indexed citations
15.
Waalkes, Sandra, Axel S. Merseburger, Thomas Herrmann, et al.. (2010). Urinary collecting system invasion is no independent prognostic factor in renal cell carcinoma. World Journal of Urology. 28(3). 283–288. 12 indexed citations
16.
Kuczyk, M., Gerd Wegener, & Udo Jonas. (2005). The Therapeutic Value of Adrenalectomy in Case of Solitary Metastatic Spread Originating from Primary Renal Cell Cancer. European Urology. 48(2). 252–257. 35 indexed citations
17.
Eckardt, A., Gerd Wegener, & Johann H. Karstens. (2005). Präoperative Radio-Chemo-Therapie fortgeschrittener, resektabler Mundhöhlenkarzinome mit Cisplatin vs. Paclitaxel/Carboplatin. Mund- Kiefer- und Gesichtschirurgie. 10(1). 30–36. 5 indexed citations
18.
Horstmann, Marcus, Axel S. Merseburger, Jürgen Serth, et al.. (2005). Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels. Journal of Cancer Research and Clinical Oncology. 131(11). 715–722. 25 indexed citations
19.
Kuczyk, M., Gerd Wegener, Axel S. Merseburger, et al.. (2005). Impact of tumor size on the long-term survival of patients with early stage renal cell cancer. World Journal of Urology. 23(1). 50–54. 9 indexed citations
20.
Regel, G., A. Seekamp, Hermann Aebert, Gerd Wegener, & J. Sturm. (1990). Bronchoscopy in severe blunt chest trauma. Surgical Endoscopy. 4(1). 31–35. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haluk Onat Breakdown of academic impact, for papers by Daniel Buitrago Breakdown of academic impact, for papers by Myles P. Cunningham Breakdown of academic impact, for papers by M. Colman Breakdown of academic impact, for papers by Yasser Khafaga Breakdown of academic impact, for papers by Yasemin Özlük Breakdown of academic impact, for papers by L. Vini Breakdown of academic impact, for papers by Mitsuji Nagahama Breakdown of academic impact, for papers by W. King Breakdown of academic impact, for papers by Kinji Nishiyama
Rankless by CCL
2026